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Skeletal muscle fitness plays vital roles in human health and disease and is determined by developmental as well as physiolog-
ical inputs. These inputs control and coordinate muscle fiber programs, including capacity for fuel burning, mitochondrial ATP 
production, and contraction. Recent studies have demonstrated crucial roles for nuclear receptors and their co-activators, and 
microRNAs (miRNAs) in the regulation of skeletal muscle energy metabolism and fiber type determination. In this review, we 
present recent progress in the study of nuclear receptor signaling and miRNA networks in muscle fiber type switching. We also 
discuss the therapeutic potential of nuclear receptors and miRNAs in disease states that are associated with loss of muscle  
fitness. 
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Skeletal muscle is the biggest organ in the human body; it 
comprises ~40% of total body mass [1,2]. As one of the 
most metabolically demanding tissues that has very active 
lipid and glucose metabolism, skeletal muscle can account 
for ~80% of insulin-stimulated glucose disposal [35]. 
Skeletal muscle fitness plays important roles in human 
health and disease. Skeletal muscle fitness is determined by 
developmental as well as physiological inputs. These inputs 
control and coordinate muscle fiber programs, including 
fuel burning, mitochondrial ATP production, and contrac-
tion. Exercise is well known to be effective in improving 
muscle fitness by promoting favorable metabolic and struc-
tural adaptations [35]. Exercise training enhances muscle 
endurance and performance by augmenting the capacity of 
mitochondria to burn glucose and fatty acids and by in-
creasing the proportion of slow oxidative fibers and blood 
supply [35]. Conversely, skeletal muscle dysfunction, in-
cluding fiber type switching and decreased oxidative capac-
ity, is a common consequence of physical inactivity, con-
tributing to the progression of many chronic illness, includ-
ing obesity, diabetes, muscular diseases and aging [2,3,5]. 
Skeletal muscle is a bundle of muscle fibers. Muscle fi-
bers can be generally classified into oxidative slow-twitch 
and glycolytic fast-twitch myofibers. Based on myosin iso-
form expression, muscle in rodents can also be classified 
into Type I, Type IIa, Type IIx and Type IIb [1,2,5,6] (Fig-
ure 1). Type I and IIa fibers are characterized by high en-
durance and are mitochondria-rich (red), relying largely on 
mitochondrial oxidative metabolism for ATP production 
[2,5,6]. In contrast, Type IIb fibers generally have low en-
durance and less mitochondria, and are mainly reliant on 
glycolytic metabolism for energy production [2,5,6]. An 
intermediate IIx fiber type has also been defined in rodents, 
but not in human. How the slow twitch fiber is linked to 
high metabolic capacity is unclear. 
Skeletal muscle exhibits remarkable plasticity, in response  
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Figure 1  Skeletal muscle fiber types. Muscle fiber typing by immuno-
fluorescence staining of gastrocnemius muscle from 3-month-old C57BL/ 
6J mice. MHC1 (green), MHC2a (blue), MHC2b (red), and MHC2x (un-
stained). 
to a variety of external stimulations; it undergoes extensive 
reprogramming to meet its energy and contraction demands. 
One of the best examples of this reprogramming is fiber 
type switching. Endurance exercise training results in an 
increased proportion of slow-twitch Type I and Type IIa 
fibers. Exercise training also increases the mitochondrial 
mass, which, in turn, increases capacity for oxidation of fat 
and glucose, and for exercise [35]. Conversely, reduced 
physical activity, such as occurs in chronic diseases states, 
results in a reduced proportion of Type I and Type IIa fibers 
[35]. Importantly, whole body insulin sensitivity and insu-
lin-stimulated glucose uptake is significantly positively 
correlated with the proportion of slow-twitch muscle fibers 
[3,4,7]. The gene regulatory circuitry that controls muscle 
fiber type switching has been partially delineated over the 
past two decades. In addition to the widely accepted cal-
cineurin/NFAT and the HDAC/MEF2 signaling pathways 
[8,9], it has recently been shown that nuclear receptor sig-
naling and miRNAs also play crucial roles in the regulation 
of skeletal muscle energy metabolism and fiber type 
switching. 
1  The PPAR subfamily of nuclear receptors 
Nuclear receptors are a class of transcription factor that can 
sense hormones (also termed ligands) and that regulate gene 
expression in response to external stimuli [1013]. The pe-
roxisome proliferator-activated receptor (PPAR) subfamily 
of nuclear receptors comprises three members, PPAR, 
PPAR, and PPAR[1013]. PPAR is highly expressed 
in oxidative tissues such as skeletal muscle, liver and heart 
[14,15]. PPAR is ubiquitously expressed, with relatively 
high levels of expression in heart, skeletal muscle and brain 
[16], while PPAR is adipose-specific and plays a vital role 
in adipocyte differentiation and fat storage [10,13]. PPARs 
form heterodimers with retinoid X receptors (RXRs) and 
bind to the PPAR response element (PPRE) in target gene 
promoters [10,17]. The activity of PPARs can be modulated 
by its expression levels, the availability of endogenous lig-
ands, and its co-activators [10,13], as described below. Both 
gain of function and loss of function studies have demon-
strated that PPAR and PPAR are key regulators of 
skeletal muscle energy metabolism and fiber type switching. 
PPAR regulates the expression of genes involved in 
almost every step of fatty acid metabolism in skeletal mus-
cle [14,15,18]. Transgenic mice, in which PPAR is over- 
expressed specifically in skeletal muscle (MCK-PPARα 
mice), have up-regulated expression of genes involved in 
fatty acid uptake, oxidation, storage, and mitochondrial ox-
idative phosphorylation, and the mice have high fatty acid 
oxidation (FAO) rates and are resistant to high-fat-diet in-
duced obesity [18]. Interestingly, MCK-PPAR mice de-
velop insulin resistance and glucose intolerance, and are 
able to run significant shorter distances than controls 
[18,19]. Gene expression profiling demonstrated that the 
expression of genes involved in glucose uptake and glycol-
ysis was decreased in MCK-PPARα mice [18,19]. Even 
more surprisingly, fiber typing analysis demonstrated a 
dramatic reduction in Type I fibers in MCK-PPARα muscle 
compared to control littermates [20]. In contrast to the gain 
of function models, PPAR-deficient mice display de-
creased muscle FAO rates, and exhibit a mild age-associ- 
ated cardiac fibrosis and an inability to compensate for in-
creased cardiac workloads [21], indicating that PPAR is 
necessary for the heart’s high capacity for burning fat. 
Moreover, PPAR-deficient muscle induces a shift in mus-
cle fiber type proportion towards a slow oxidative type [20]. 
Taken together, although PPAR can potently activate mi-
tochondrial FAO, it is also a repressor of slow-oxidative 
muscle fiber gene expression; therefore, its activity needs to 
be finely regulated in skeletal muscle.  
PPAR can also potently activate the expression of 
genes involved in fatty acid metabolism in skeletal muscle 
[19,20,2225]. Surprisingly, transgenic mice, in which 
PPAR is over-expressed specifically in skeletal muscle, 
have a phenotype that is remarkably different from that of 
the muscle-specific PPAR transgenic mice, despite the 
fact that both lines have increased capacity for mitochondri-
al FAO [19,20,2325]. Three independent studies have 
demonstrated that over-expression of PPAR in skeletal 
muscle induces a slow-oxidative muscle fiber program 
[20,24,25]. Mice over-expressing a constitutively active  
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form of PPAR in skeletal muscle have increased endur-
ance of more than 100% [25]. Consistently, the number of 
Type I muscle fibers is increased in the transgenic muscle 
and the mice are resistant to high-fat-diet induced obesity 
and have improved glucose tolerance [25]. Mice expressing 
a native PPAR protein also induce high FAO gene ex-
pression, and have more oxidative fibers than controls 
[20,24]. The MCK-PPAR mice exhibit many of the 
metabolic benefits of exercise, despite the absence of exer-
cise training, including increased muscle glucose utilization 
[19,20]. For example, the MCK-PPAR mice have superb 
exercise capacity on a motorized treadmill; interestingly, 
this phenotype is more apparent with a high-intensity exer-
cise protocol. Muscle glycogen levels are also significantly 
increased in the MCK-PPAR mice [19]. The most strik-
ing phenotype is that PPAR drives a complete shift to-
wards a type I oxidative muscle fiber type program. Fiber 
type staining demonstrated a 100% increase in Type I fibers 
in MCK-PPAR soleus muscle [20]. Analysis of tran-
scripts encoding the myosin heavy chain (MHC) isoforms 
revealed an increased expression of Type I MHC in 
MCK-PPAR muscle, whereas the levels of MHC Type 
IIa, IIx, and IIb mRNAs were markedly suppressed [20]. 
Moreover, several slow-twitch troponin genes are induced 
and fast twitch troponin genes suppressed in MCK- 
PPAR muscle [20]. In contrast to the muscle-specific 
PPAR transgenic mice, skeletal muscle-specific 
PPAR-null mice exhibit a shift towards a greater propor-
tion of glycolytic-type muscle fibers. These mice have de-
creased expression of FAO genes. On a high-fat-diet, the 
mice gain more weight and are more prone than controls to 
developing insulin resistance and glucose intolerance [26]. 
Taken together, these data demonstrate that PPAR is 
necessary for both muscle FAO and the Type I fiber pro-
gram, and that activation of PPAR in skeletal muscle can 
coordinately regulate muscle energy metabolism and fiber 
type switching to improve muscle fitness.  
2  The PGC-1 co-activator 
The discovery of PPAR coactivator-1 (PGC-1) as a 
coactivator of PPAR in brown adipose tissue by the labor-
atory of Bruce Speigelman has provided significant insight 
into how PPARs and other nuclear receptors are regulated 
in response to the physiological and nutritional states of 
skeletal muscle [2732]. PGC-1 is a member of a family 
of transcriptional coactivators that includes PGC-1, 
PGC-1 and the PGC-1-related coactivator (PRC) [2932]. 
PGC-1 has significant homology with PGC-1 and shares 
many of its functions in skeletal muscle [33,34]. PGC-1 
co-activates a number of transcription factors including the 
PPAR and estrogen-related receptor (ERR) nuclear recep- 
ors, the nuclear respiratory factors 1/2 (NRF1/NRF2) and 
MEF2 [2932,35]. PGC-1 directly interacts with its target 
transcription factors, serving to recruit molecules that medi-
ate chromatin remodeling via histone acetyltransferase 
(HAT) activity, and by recruiting components of the tran-
scriptional machinery, such as RNA polymerase II to acti-
vate gene transcription [2932]. PGC-1 expression can be 
induced by a variety of physiological stimuli, such as cold 
exposure, fasting, and exercise [2732,3638]. Thus, 
PGC-1 can orchestrate the activity of multiple transcrip-
tion factors in response to a variety of external stimuli to 
control metabolic and structural adaptations in muscle. 
Extensive studies have supported a critical role for 
PGC-1 coactivators in skeletal muscle [3948]. The first 
evidence came with observations in animal models and hu-
mans that PGC-1 gene expression is induced in skeletal 
muscle in physiological conditions that require increased 
energy expenditure, such as exercise [36,40,41]. Gain-of- 
function studies performed in cultured myocytes have 
shown that PGC-1 is capable of activating virtually all 
aspects of mitochondrial biogenesis in muscle cells, includ-
ing increased expression of oxidative phosphorylation and 
FAO genes, increased number of mitochondria, and en-
hanced mitochondrial respiratory capacity [42]. Transgenic 
systems and gene knockout (KO) approaches have been 
used to define the physiological roles of PGC-1 coactivators 
in skeletal muscle. Two independent studies have shown 
that over-expression of PGC-1 in skeletal muscle induces 
an oxidative fiber-type transformation [43,44]. Forced 
over-expression of PGC-1 under a muscle specific MCK 
promoter increases muscle oxidative capacity and the pro-
portions of Type I and IIa fibers [43]. A skeletal mus-
cle-specific, tetracycline-regulated PGC-1 over-expression 
system has also been employed to mimic the induction of 
PGC-1 known to occur post-exercise. Induced expression 
of PGC-1 in adult skeletal muscle triggered mitochondrial 
biogenesis, increased “red” muscle, and expanded muscle 
glycogen stores, key features of exercise training [44]. In-
terestingly, a short form of PGC-1PGC-1has been 
recently shown to induce muscle hypertrophy [49], while 
full length PGC-1was shown to regulate kynurenine me-
tabolism and to protect mice from stress-induced depression 
[50]. Taken together, the gain of function study results sug-
gest that induction of PGC-1, which is known to occur 
following exercise, drives a trained skeletal muscle pheno-
type. 
Mice with targeted ablation of the genes encoding either 
PGC-1 or PGC-1β have a minimal phenotype until they 
are challenged with a physiological stress that increases 
demand for ATP production [33,34,4548]. For example, 
PGC-1 KO mice have reduced exercise capacity on a 
treadmill compared to wild-type controls [47,48], while 
combined deficiency of PGC-1 and PGC-1 in skeletal 
muscle results in a dramatic exercise performance deficit 
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related to mitochondrial dysfunction [39]. The exercise 
phenotype of muscle-specific PGC-1 double-KO mice is 
associated with a marked decrease in muscle respiratory 
capacity and derangement of mitochondrial structure [39]. 
In addition, the conventional PGC-1 double-KO mice 
die soon after birth with heart failure [51]. Studies of 
PGC-1 double-KO heart sections by electron microsco-
py revealed that the normal perinatal mitochondrial biogen-
ic response was completely absent [51]. Thus, these results 
of phenotypic analyses of the PGC-1- and PGC-1-   
deficient mice have shown that both coactivators are neces-
sary for mitochondrial respiratory function in skeletal mus-
cle and heart. However, despite severe mitochondrial ab-
normalities, the proportion of Type I and IIa fibers was not 
diminished in PGC-1 double-KO muscle [39], suggest-
ing that PGC-1deficiency triggers an adaptive repro-
gramming in skeletal muscle. These results support a sur-
prising conclusion that the PGC-1 coactivators are dispen-
sable for fundamental fiber type determination. Given that 
PGC-1 is induced by exercise training, it’s still very likely 
that the induction of PGC-1 could have a booster function 
on muscle fiber type switching via its coactivating effects 
on downstream effecters such as PPAR. 
3  Role of miRNAs in skeletal muscle fiber type 
determination  
The recent breakthrough discovery of miRNAs as key play-
ers of gene regulation has unveiled a new dimension in the 
control of gene expression [5257]. miRNAs are a family of 
small RNA molecules, usually 22 nucleotides long, that 
were first identified in C. elegans in the early 1990s [58,59]. 
Since then, miRNAs have been discovered in virtually all 
plants and mammals [6062]. Many miRNAs are encoded 
in the introns of host genes, indicating that they are 
co-regulated with their host genes. miRNAs are transcribed 
by RNA polymerase II and after processing by the RNase 
III enzyme, Drosha, pre-miRNAs are exported to the cyto-
plasm to be further processed by Dicer [52,55]. Mature 
miRNAs are incorporated into the RNA-induced silencing 
complex (RISC), where they bind to their mRNA targets 
[52,55,63,64]. miRNAs can regulate gene expression either 
through translational repression or direct gene silencing 
[52,55,64]. Interestingly, miRNAs usually modulate a class 
of mRNA targets that share the same function, thereby con-
trolling complex biological processes.  
Evidence is emerging that gene regulatory programs in-
volved in skeletal muscle biology involve miRNAs 
[53,54,56,6567]. Several miRNAs, named “MyomiRs”, 
have been shown by Eric Olson’s laboratory, to be involved 
in muscle fiber type programs [65]. Specifically, miR-208b, 
which is encoded within a type I MHC gene (Myh7), and 
miR-499, which is encoded within another type I MHC 
gene (Myh7b), have been shown to drive a slow-twitch fiber 
program by down-regulating transcriptional repressors that 
suppress slow-twitch contractile protein gene expression 
[65,68]. The 3′-UTRs of Sox6 and PurB contain conserved 
target sites for both miR-499 and miR-208b, each of which 
has been reported to repress Type I marker expression 
[65,68,69]. In addition, gain-of-function and loss-of-  
function studies in mice have identified an important role 
for Sox6 in muscle development, fiber type specification, 
and muscle performance [7072].  
Interestingly, muscle-specific miR-499 transgenic mice 
run over 50% longer than wild-type littermates when sub-
jected to a regimen of forced treadmill running [65], indi-
cating an endurance exercise training phenotype in these 
mice. Moreover, the miR-499 transgenic background com-
pletely reverses the exercise performance deficit of 
MCK-PPAR mice (the “couch potato” mouse) [20], fur-
ther supporting a dominant role of miR-499 in muscle 
physiology. Importantly, miR-499 is relevant in humans. 
The expression levels of miR-499 are significantly in-
creased in human muscle biopsies from trained athletes 
compared to sedentary controls [20]. In addition, there is a 
significant positive correlation between the expression of 
miR-499 and Type I fiber %, ATPmax, and VO2max in 
humans [20]. Taken together, these results demonstrate that 
miR-499 is linked to both the Type I muscle program and to 
metabolic capacity in humans, providing an important 
translational relevance. 
4  Cross talk between nuclear receptor signaling 
and miRNA networks 
Accumulating evidence suggests that there is a cross talk 
between nuclear receptor signaling and miRNA networks. 
An interesting connection between PPARs and miRNAs has 
been discovered in a miRNA expression profiling study 
with RNA isolated from MCK-PPARs mice [20]. Con-
sistent with the strikingly different phenotypes between the 
MCK-PPAR and MCK-PPAR mice, the miRNA expre- 
ssion patterns were remarkably different among the MCK- 
PPARs lines and a subset of miRNAs exhibited reciprocal 
regulation [20]. For example, levels of miR-208b and 
miR-499 are significantly increased in MCK-PPAR 
muscle but dramatically reduced in MCK-PPAR muscle 
[20]. Gain- and loss-of-function studies in primary skeletal 
muscle cells have demonstrated that PPAR and PPAR 
have opposing roles in the regulation of the Type I fiber 
program through this miR-499/208b circuit [20]. These re-
sults support a model in which PPAR signaling is upstream 
of miR-208b/miR-499 and that PPAR activates, while 
PPAR suppresses, the miRNA circuit in muscle.  
Interestingly, no consensus PPAR binding sites have 
been identified in the miR-499/208b promoters. However, 
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highly conserved sites for another nuclear receptor, ERR, 
were identified in both miRNA promoters [20]. ERR has 
been shown to promote the Type I fiber program in skeletal 
muscle [73]. ERR is suggested to bridge the gap between 
PPAR and the increase in miR-499/208b expression 
given that levels of ERR protein were increased in 
MCK-PPAR muscle [20]. Moreover, chromatin im-
munoprecipitation (ChIP) of the miR-499/208b promoters 
demonstrated that ERR occupies the region containing the 
proposed ERR response elements [20]. As expected, levels 
of miR-499 and miR-208b are dramatically reduced in the 
ERR double KO muscle [20]. Therefore, ERR serves a 
critical role in the Type I fiber program by directly activat-
ing transcription of miRNA genes via a highly conserved 
ERR response element. It is very likely that PGC-1 could 
have a booster function on this mechanism via its coacti-
vating effects on ERR and PPAR. 
In contrast to PPAR and ERR, PPAR exerts a re-
pression effect on miR-499 and miR-208b [20]. Interest-
ingly, this effect seams independent of exogenously added 
PPAR ligand and promoter mapping indicates that PPAR 
suppresses miR-208b promoter activity through the proxi-
mal promoter region [20].  
5  Conclusion and perspectives  
It is clear that a sedentary life style is a major risk factor for 
many chronic diseases and that chronic diseases, such as 
obesity, diabetes, and muscular diseases, are associated with 
decreased muscle fitness [2,3,5]. Exercise is well known to 
enhance muscle fitness. Genetically modified mouse models 
have demonstrated that there is a nuclear receptor-miRNA 
circuit that orchestrates programs controlling muscle energy 
metabolism and fiber type (Figure 2): (i) PGC-1PPAR
/ERR signaling can drive a trained muscle fiber program; 
(ii) surprisingly, the closely-related nuclear receptors, 
PPAR and PPAR exert opposing actions upon fiber 
type programs through a muscle miRNA network; (iii) 
PPAR activates ERR which drives the miR-208b/499 
circuit and, thus, the Type I fiber program; (iv) studies of 
human muscle confirmed that this circuit links control of 
muscle fiber type with metabolic energy capacity. This new 
information has provided important insight into the role of 
nuclear receptor signaling and miRNAs networks in muscle 
fiber type switching.   
Given the recent exciting evidence that the expression of 
ERR and miR-499 are linked to human fitness [20], the 
nuclear receptor/miRNA regulatory circuit shows promise 
as a therapeutic target aimed at enhancing muscle fitness in 
a variety of chronic disease states that are associated with 
loss of muscle fitness, including but not limited to, obesity, 
diabetes, muscular disease, and aging [74]. It will be im-
portant to fully define the downstream targets of the nuclear 
 
Figure 2 (color online)  Model of nuclear receptor signaling and a miR-
NA network in the control of muscle fiber type switching. The schematic 
depicts a proposed model for a nuclear receptor-miRNA circuit that con-
trols the muscle Type I fiber program. PPAR, ERR and probably 
ERR activate miR-208b and miR-499 triggering a Type I fiber program 
while PPAR suppresses the program. The effect of exercise could stimu-
late this program via the transcriptional coactivator PGC-1.  
receptor-miRNA networks involved in the coordinated reg-
ulation of metabolic and structural programs in muscle. Fu-
ture studies aimed at targeting the PPAR, ERR and 
miR-499 components of the circuit will be of interest. Of 
note, nuclear receptors form the second largest class of drug 
targets, with an estimated share of 10%15% of the global 
pharmaceutical market. In addition, direct manipulation of 
miR-499 levels in muscle through biological approaches is 
also warranted. We are optimistic that one day a trained 
effect can be attained without exercise training by taking an 
“exercise pill”. 
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